Redeye: Binero - Better-than-expected EBITDA
Redeye makes forecast adjustments following Binero’s Q3 2022 report, which saw revenues somewhat below our expectations but an EBITDA clearly above. Consequently, our forecast adjustments slightly affect our fair value range.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking.